Literature DB >> 8849216

Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.

D J Griggs1, K Gensberg, L J Piddock.   

Abstract

The quinolone resistance-determining regions (QRDRs) of the gyrA genes of quinolone-resistant clinical and veterinary salmonella isolates were sequenced. Substitutions analogous to a substitution of a Ser to a Phe at position 83 (Ser83-->Phe) and Asp87-->Gly or Tyr in Escherichia coli were found, as was a single novel mutation outside of the QRDR resulting in Ala119-->Glu. The data suggest that gyrA mutations are associated with quinolone resistance in veterinary and clinical salmonella isolates and that the limits of the QRDR may require revision.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849216      PMCID: PMC163248     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Quinolones for the treatment of infections due to Salmonella.

Authors:  C E Cherubin; R H Eng
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

2.  Multiresistant Salmonella and fluoroquinolones.

Authors:  C S Lewin; L S Nandivada; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1991-01       Impact factor: 5.790

3.  4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction.

Authors:  M Oram; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

4.  Quinolone resistance in Salmonella spp: veterinary pointers.

Authors:  L J Piddock; C Wray; I McClaren; R Wise
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

5.  Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess.

Authors:  A P Gibb; C S Lewin; O J Garden
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

6.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

Authors:  H P Endtz; G J Ruijs; B van Klingeren; W H Jansen; T van der Reyden; R P Mouton
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

7.  A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex.

Authors:  C J Willmott; A Maxwell
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

8.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

9.  Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients.

Authors:  L J Piddock; D J Griggs; M C Hall; Y F Jin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance.

Authors:  F Reyna; M Huesca; V González; L Y Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  52 in total

1.  Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium.

Authors:  L J Piddock; D G White; K Gensberg; L Pumbwe; D J Griggs
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes.

Authors:  J McKinney; C Guerrier-Takada; D Wesolowski; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

3.  Specific gyrA mutation at codon 83 in nalidixic acid-resistant Salmonella enterica serovar Typhi strains isolated from Vietnamese patients.

Authors:  Le Van Phung; Haruko Ryo; Taisei Nomura
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  gyrA Mutations associated with nalidixic acid-resistant salmonellae from wild birds.

Authors:  M Paloma Reche; José E García de los Ríos; Pedro A Jiménez; Ana M Rojas; Rafael Rotger
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

5.  Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.

Authors:  D Dagan; N Orr; M Yavzori; Y Yuhas; D Meron; S Ashkenazi; D Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

6.  Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.

Authors:  Ketaki Soparkar; Alfred D Kinana; Jon W Weeks; Keith D Morrison; Hiroshi Nikaido; Rajeev Misra
Journal:  J Bacteriol       Date:  2015-08-03       Impact factor: 3.490

7.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

8.  DNA diagnostics by surface-bound melt-curve reactions.

Authors:  Linda Strömqvist Meuzelaar; Katie Hopkins; Ernesto Liebana; Anthony J Brookes
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

9.  DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.

Authors:  Kenji Hirose; Ai Hashimoto; Kazumichi Tamura; Yoshiaki Kawamura; Takayuki Ezaki; Hiroko Sagara; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.

Authors:  Antti Hakanen; Jari Jalava; Pirkko Kotilainen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.